JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v9i7.11397ArticleApplication Value of Pathological Examination in Gynecological Physical Examination https://artdesignp.com/journal/JCNR/9/7/10.26689/jcnr.v9i7.11397LiLiuyan,ZhangXiaohui2025972025-08-01Objective: To study the application value and application path of pathological examination in gynecological physical examination. Methods: A total of 1200 patients undergoing gynecological physical examination in X Hospital from January 2024 to December 2024 were selected. All patients received cervical Pap smear examination, and patients with abnormal examination results underwent colposcopic biopsy and HPV infection test for cervical cancer screening. Results: The results of cervical Pap smear showed that a total of 780 patients among 1200 patients showed cervical abnormalities. The Pap smear combined with colposcopy was used for pathological examination to detect cervical cancer lesions in time, and biopsy and HPV infection examination were arranged for high-risk patients to provide data reference for clinical treatment. Conclusions: Pathological examination has a good screening effect in gynecological physical examination. It can detect lesions early and take timely intervention measures, which is helpful to reduce the incidence and mortality of the disease.

Ma Y, Xiao TJ, Zhang BH, et al., 2024, Analysis of Human Papillomavirus Infection, Liquid-Based Thin-Layer Cytology and Vaginal Microecology in Gynecological Examination Population. Physician-online, 14(6): 7–11.

Li L, Liu X, Zhang Q, et al., 2024, Application of High-Risk HPV and HPV16/18 Detection in Cervical Cancer Screening and Health Management. 2024 Symposium on Intelligent Medical Care and Rehabilitation Management, 2024: 1–4.

Yuan L, 2021, Fertility-Preserving Surgery for 165 Cases of Young Patients with Early Ovarian Borderline Tumors, thesis, Zhengzhou University.

Wang Y, Li Y, Li Y, et al., 2020, Blood Routine Test Results of Gynecological Pelvic Malignant Tumors. Advances in Modern Biomedicine, 20(8): 1569–1574.

Yin HJ, 2020, Study on Combined Detection of Human Papillomavirus and Tumor Markers in Cervical Cancer Screening, thesis, North China University of Science and Technology.

Yang JH, 2023, Analysis of the Role of Pathological Examination in Gynecological Physical Examination. Self-care, 27(1): 148–149.

Zung YW, Lu JP, 2020, Research on the Application Value of Pathological Examination in Gynecological Physical Examination. International Infectious Diseases (Electronic Edition), 9(2): 359.

Song GQ, 2024, Application Effect of Cervical Exfoliated Cells HPV Combined with TCT in Cervical Cancer Screening. Weekly Digest · Senior Care Weekly, (14): 284–286.

Wu H, Wang W, Hu J, 2023, The Role of Cervical Liquid-Based Cytology in Cervical Cancer Screening. Heilongjiang Medicine, 36(6): 1402–1405.

Zhu KK, Zhang K, Guo RL, et al., 2024, Evaluation of the Value of Human Papillomavirus E6/E7 mRNA Combined with Cell Ploidy Test in Cervical Cancer Screening. Xinjiang Med, 54(12): 1438–1441.

Tang L, Yang S, Mao Q, 2024, Expression of Serum SOX2 and PD-L1 in 140 Cases of Chronic Cervicitis Complicated with HPV Infection and Its Correlation with Clinicopathological Features. Anhui Medicine, 28(10): 2030–2034.

Ou H, Hu X, Li J, et al., 2023, Expression and Clinical Significance of Serum Asprosin, miR-206 and IMA in Patients with Polycystic Ovary Syndrome. Journal of Difficult and Difficult Diseases, 22(10): 1078–1083, 1089.

Luo S, 2021, The Correlation Analysis of Serum IFN-γ, IL-4 Levels with Serum Follicle-Stimulating Hormone, Testosterone Levels in Infertile Patients with Polycystic Ovary Syndrome. Minimally Invasive Medicine, 17(6): 764–766.

Chen YH, Gu MH, Xie F, 2021, Correlation Analysis of Serum Related Indicators with Clinicopathological Characteristics and Prognosis in Patients with Cervical Cancer. Chinese Maternal and Child Health Care, 37(20): 3707–3711.

Ma H, Li Y, Zhu X, et al., 2021, Diagnostic Efficiency of SCC-Ag and HPV Typing Combined with p53 Detection in Early Screening of Cervical Cancer. Journal of Molecular Diagnosis and Therapy, 16(11): 2016–2020.